Umbilical cord blood transplantation from unrelated HLA-matched donor in an adult with severe aplastic anemia
Authors:
- 1 November 2000
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (10) , 1121-1123
Abstract
A 23-year-old male suffering from severe aplastic anemia (SAA) weighing 60 kg was successfully treated by unrelated allo-CBSCT (cord blood stem cell transplantation). A six-loci HLA-identical umbilical cord blood (UCB) was infused after conditioning with low-dose cyclophosphamide (CTX) and antilymphocyte globulin (ALG). The prophylaxis of GVHD consisted of CsA and MTX. The infused cord blood provided 1.89 × 107 nucleated cells per kg, cd34-positive cells: 0.89%. neutrophils >0.5 × 109/l were reached 10 days after transplant, and platelets greater than 50.0 × 109/l at day 26. RBC and platelet transfusion independence were reached on days 15 and 18. The patient developed grade 1 skin GVHD 10 months after engraftment of the donor cells. Microsatellite DNA fingerprinting indicated a stable and persistent donor–recipient mixed chimerism, whilst the circulating red cells remain of host origin. Bone Marrow Transplantation (2000) 26, 1121–1123.Keywords
This publication has 5 references indexed in Scilit:
- Primary Treatment of Acquired Aplastic Anemia: Outcomes with Bone Marrow Transplantation and Immunosuppressive TherapyAnnals of Internal Medicine, 1997
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsNew England Journal of Medicine, 1996
- Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiencyTransfusion, 1996
- Molecular follow‐up of patients after bone marrow transplantationStem Cells, 1993
- Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantationGlycobiology, 1992